866-997-4948(US-Canada Toll Free)

United States Cancer Monoclonal Antibodies Market Report 2017

Published By :

QYResearch

Published Date : Mar 2017

Category :

Cancer

No. of Pages : 107 Pages

Notes:
Sales, means the sales volume of Cancer Monoclonal Antibodies
Revenue, means the sales value of Cancer Monoclonal Antibodies

This report studies sales (consumption) of Cancer Monoclonal Antibodies in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
F. Hoffmann-La Roche
Amgen
Bristol-Myers Squibb
Takeda Pharmaceuticals
AstraZeneca
Bayer
Merck
Janssen Biotech
Novartis
OncoMed Pharmaceuticals
Pfizer
Eli Lilly
Sanofi
TG Therapeutics
CTI BioPharma
Intas Pharmaceuticals
Boehringer Ingelheim
Biogen

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Naked MAbs
Conjugated MAbs
Split by applications, this report focuses on sales, market share and growth rate of Cancer Monoclonal Antibodies in each application, can be divided into
Immune System Suppressors
Kill or Inhibit Malignant Cells
Deliver Chemotherapy To Cancer Cells

Table of Contents

United States Cancer Monoclonal Antibodies Market Report 2017
1 Cancer Monoclonal Antibodies Overview
1.1 Product Overview and Scope of Cancer Monoclonal Antibodies
1.2 Classification of Cancer Monoclonal Antibodies
1.2.1 Naked MAbs
1.2.2 Conjugated MAbs
1.3 Application of Cancer Monoclonal Antibodies
1.3.1 Immune System Suppressors
1.3.2 Kill or Inhibit Malignant Cells
1.3.3 Deliver Chemotherapy To Cancer Cells
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Cancer Monoclonal Antibodies (2012-2022)
1.4.1 United States Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2022)
1.4.2 United States Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2022)

2 United States Cancer Monoclonal Antibodies Competition by Manufacturers
2.1 United States Cancer Monoclonal Antibodies Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Cancer Monoclonal Antibodies Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Cancer Monoclonal Antibodies Average Price by Manufactures (2015 and 2016)
2.4 Cancer Monoclonal Antibodies Market Competitive Situation and Trends
2.4.1 Cancer Monoclonal Antibodies Market Concentration Rate
2.4.2 Cancer Monoclonal Antibodies Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Cancer Monoclonal Antibodies Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Cancer Monoclonal Antibodies Sales and Market Share by States (2012-2017)
3.2 United States Cancer Monoclonal Antibodies Revenue and Market Share by States (2012-2017)
3.3 United States Cancer Monoclonal Antibodies Price by States (2012-2017)

4 United States Cancer Monoclonal Antibodies Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Cancer Monoclonal Antibodies Sales and Market Share by Type (2012-2017)
4.2 United States Cancer Monoclonal Antibodies Revenue and Market Share by Type (2012-2017)
4.3 United States Cancer Monoclonal Antibodies Price by Type (2012-2017)
4.4 United States Cancer Monoclonal Antibodies Sales Growth Rate by Type (2012-2017)

5 United States Cancer Monoclonal Antibodies Sales (Volume) by Application (2012-2017)
5.1 United States Cancer Monoclonal Antibodies Sales and Market Share by Application (2012-2017)
5.2 United States Cancer Monoclonal Antibodies Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Cancer Monoclonal Antibodies Manufacturers Profiles/Analysis
6.1 F. Hoffmann-La Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Amgen
6.2.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Amgen Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Bristol-Myers Squibb
6.3.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Takeda Pharmaceuticals
6.4.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 AstraZeneca
6.5.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 AstraZeneca Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Bayer
6.6.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Bayer Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Merck
6.7.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Merck Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Janssen Biotech
6.8.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Janssen Biotech Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Novartis
6.9.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Novartis Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 OncoMed Pharmaceuticals
6.10.2 Cancer Monoclonal Antibodies Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 OncoMed Pharmaceuticals Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Pfizer
6.12 Eli Lilly
6.13 Sanofi
6.14 TG Therapeutics
6.15 CTI BioPharma
6.16 Intas Pharmaceuticals
6.17 Boehringer Ingelheim
6.18 Biogen

7 Cancer Monoclonal Antibodies Manufacturing Cost Analysis
7.1 Cancer Monoclonal Antibodies Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cancer Monoclonal Antibodies

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Cancer Monoclonal Antibodies Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cancer Monoclonal Antibodies Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Cancer Monoclonal Antibodies Market Forecast (2017-2022)
11.1 United States Cancer Monoclonal Antibodies Sales, Revenue Forecast (2017-2022)
11.2 United States Cancer Monoclonal Antibodies Sales Forecast by Type (2017-2022)
11.3 United States Cancer Monoclonal Antibodies Sales Forecast by Application (2017-2022)
11.4 Cancer Monoclonal Antibodies Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Cancer Monoclonal Antibodies
Table Classification of Cancer Monoclonal Antibodies
Figure United States Sales Market Share of Cancer Monoclonal Antibodies by Type in 2015
Figure Naked MAbs Picture
Figure Conjugated MAbs Picture
Table Application of Cancer Monoclonal Antibodies
Figure United States Sales Market Share of Cancer Monoclonal Antibodies by Application in 2015
Figure Immune System Suppressors Examples
Figure Kill or Inhibit Malignant Cells Examples
Figure Deliver Chemotherapy To Cancer Cells Examples
Figure United States Cancer Monoclonal Antibodies Sales and Growth Rate (2012-2022)
Figure United States Cancer Monoclonal Antibodies Revenue and Growth Rate (2012-2022)
Table United States Cancer Monoclonal Antibodies Sales of Key Manufacturers (2015 and 2016)
Table United States Cancer Monoclonal Antibodies Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Monoclonal Antibodies Sales Share by Manufacturers
Figure 2016 Cancer Monoclonal Antibodies Sales Share by Manufacturers
Table United States Cancer Monoclonal Antibodies Revenue by Manufacturers (2015 and 2016)
Table United States Cancer Monoclonal Antibodies Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Cancer Monoclonal Antibodies Revenue Share by Manufacturers
Table 2016 United States Cancer Monoclonal Antibodies Revenue Share by Manufacturers
Table United States Market Cancer Monoclonal Antibodies Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Cancer Monoclonal Antibodies Average Price of Key Manufacturers in 2015
Figure Cancer Monoclonal Antibodies Market Share of Top 3 Manufacturers
Figure Cancer Monoclonal Antibodies Market Share of Top 5 Manufacturers
Table United States Cancer Monoclonal Antibodies Sales by States (2012-2017)
Table United States Cancer Monoclonal Antibodies Sales Share by States (2012-2017)
Figure United States Cancer Monoclonal Antibodies Sales Market Share by States in 2015
Table United States Cancer Monoclonal Antibodies Revenue and Market Share by States (2012-2017)
Table United States Cancer Monoclonal Antibodies Revenue Share by States (2012-2017)
Figure Revenue Market Share of Cancer Monoclonal Antibodies by States (2012-2017)
Table United States Cancer Monoclonal Antibodies Price by States (2012-2017)
Table United States Cancer Monoclonal Antibodies Sales by Type (2012-2017)
Table United States Cancer Monoclonal Antibodies Sales Share by Type (2012-2017)
Figure United States Cancer Monoclonal Antibodies Sales Market Share by Type in 2015
Table United States Cancer Monoclonal Antibodies Revenue and Market Share by Type (2012-2017)
Table United States Cancer Monoclonal Antibodies Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cancer Monoclonal Antibodies by Type (2012-2017)
Table United States Cancer Monoclonal Antibodies Price by Type (2012-2017)
Figure United States Cancer Monoclonal Antibodies Sales Growth Rate by Type (2012-2017)
Table United States Cancer Monoclonal Antibodies Sales by Application (2012-2017)
Table United States Cancer Monoclonal Antibodies Sales Market Share by Application (2012-2017)
Figure United States Cancer Monoclonal Antibodies Sales Market Share by Application in 2015
Table United States Cancer Monoclonal Antibodies Sales Growth Rate by Application (2012-2017)
Figure United States Cancer Monoclonal Antibodies Sales Growth Rate by Application (2012-2017)
Table F. Hoffmann-La Roche Basic Information List
Table F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Takeda Pharmaceuticals Basic Information List
Table Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Takeda Pharmaceuticals Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Janssen Biotech Basic Information List
Table Janssen Biotech Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Biotech Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table OncoMed Pharmaceuticals Basic Information List
Table OncoMed Pharmaceuticals Cancer Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table OncoMed Pharmaceuticals Cancer Monoclonal Antibodies Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Eli Lilly Basic Information List
Table Sanofi Basic Information List
Table TG Therapeutics Basic Information List
Table CTI BioPharma Basic Information List
Table Intas Pharmaceuticals Basic Information List
Table Boehringer Ingelheim Basic Information List
Table Biogen Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Monoclonal Antibodies
Figure Manufacturing Process Analysis of Cancer Monoclonal Antibodies
Figure Cancer Monoclonal Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Cancer Monoclonal Antibodies Major Manufacturers in 2015
Table Major Buyers of Cancer Monoclonal Antibodies
Table Distributors/Traders List
Figure United States Cancer Monoclonal Antibodies Production and Growth Rate Forecast (2017-2022)
Figure United States Cancer Monoclonal Antibodies Revenue and Growth Rate Forecast (2017-2022)
Table United States Cancer Monoclonal Antibodies Production Forecast by Type (2017-2022)
Table United States Cancer Monoclonal Antibodies Consumption Forecast by Application (2017-2022)
Table United States Cancer Monoclonal Antibodies Sales Forecast by States (2017-2022)
Table United States Cancer Monoclonal Antibodies Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *